101 related articles for article (PubMed ID: 17968885)
1. In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review.
Capizzano AA; Jorge RE; Acion LC; Robinson RG
J Magn Reson Imaging; 2007 Dec; 26(6):1378-89. PubMed ID: 17968885
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
Cecil KM; DelBello MP; Sellars MC; Strakowski SM
J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
[TBL] [Abstract][Full Text] [Related]
3. Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.
de Araújo Filho GM; Lin K; Lin J; Peruchi MM; Caboclo LO; Guaranha MS; Guilhoto LM; Carrete H; Yacubian EM
Epilepsia; 2009 May; 50(5):1201-9. PubMed ID: 19400877
[TBL] [Abstract][Full Text] [Related]
4. Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.
Guan JT; Xu XH; Geng YQ; Yu XJ; Wu RH
Brain Res; 2008 Aug; 1227():221-5. PubMed ID: 18602897
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.
Scherk H; Backens M; Schneider-Axmann T; Kemmer C; Usher J; Reith W; Falkai P; Gruber O
Acta Psychiatr Scand; 2008 Apr; 117(4):283-8. PubMed ID: 18205896
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
Franczak M; Prost RW; Antuono PG; Mark LP; Jones JL; Ulmer JL
J Comput Assist Tomogr; 2007; 31(5):666-70. PubMed ID: 17895774
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy in school-aged autistic children.
Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP
J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
9. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study.
Senaratne R; Milne AM; MacQueen GM; Hall GB
Psychiatry Res; 2009 Jun; 172(3):205-9. PubMed ID: 19386476
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy.
Modi S; Bhattacharya M; Sekhri T; Rana P; Tripathi RP; Khushu S
Magn Reson Imaging; 2008 Apr; 26(3):420-5. PubMed ID: 18164573
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
[TBL] [Abstract][Full Text] [Related]
12. Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.
Hermens DF; Naismith SL; Chitty KM; Lee RS; Tickell A; Duffy SL; Paquola C; White D; Hickie IB; Lagopoulos J
Eur Neuropsychopharmacol; 2015 Jun; 25(6):836-45. PubMed ID: 25795519
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
Kaymak SU; Demir B; Oğuz KK; Sentürk S; Uluğ B
Psychiatry Clin Neurosci; 2009 Jun; 63(3):350-6. PubMed ID: 19566767
[TBL] [Abstract][Full Text] [Related]
14. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
[TBL] [Abstract][Full Text] [Related]
15. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
16. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
17. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of functional MRI markers in mild cognitive impairment.
Zhang B; Li M; Sun ZZ; Zhu B; Yuan L; Wang Y; Xu Y
J Clin Neurosci; 2009 May; 16(5):635-41. PubMed ID: 19264490
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
Port JD; Unal SS; Mrazek DA; Marcus SM
Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder.
Sparkes SJ; MacMaster FP; Carrey NC
Brain Cogn; 2004 Mar; 54(2):173-5. PubMed ID: 15025062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
